0001104659-22-011493.txt : 20220203 0001104659-22-011493.hdr.sgml : 20220203 20220203190348 ACCESSION NUMBER: 0001104659-22-011493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniels Eric Joseph CENTRAL INDEX KEY: 0001892943 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 22590263 MAIL ADDRESS: STREET 1: C/O EYEGATE PHARMACEUTICALS INC. STREET 2: 271 WAVERLY OAKS RD., STE 108 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1371 EAST 2100 SOUTH STREET 2: SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84105 BUSINESS PHONE: (781) 788-8869 MAIL ADDRESS: STREET 1: 1371 EAST 2100 SOUTH STREET 2: SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84105 FORMER COMPANY: FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060811 4 1 tm225348d4_4.xml OWNERSHIP DOCUMENT X0306 4 2022-02-01 0 0001372514 KIORA PHARMACEUTICALS INC KPRX 0001892943 Daniels Eric Joseph C/O KIORA PHARMACEUTICALS, INC. 1371 E. 2100 SOUTH, SUITE 200 SALT LAKE CITY UT 84105 0 1 0 0 Chief Development Officer Stock Option (right to buy) 0.77 2022-02-01 4 A 0 25000 0 A 2032-02-01 Common Stock 25000 25000 D The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years. /s/ Sarah Romano, Attorney-in-Fact* 2022-02-03